Published in Ann Thorac Surg on April 01, 2003
Current treatment and outcome of esophageal perforations in adults: systematic review and meta-analysis of 75 studies. World J Surg (2013) 2.21
Esophageal perforation: principles of diagnosis and surgical management. Surg Today (2006) 1.60
Fully covered self-expandable metal stents (SEMS), partially covered SEMS and self-expandable plastic stents for the treatment of benign esophageal ruptures and anastomotic leaks. BMC Gastroenterol (2012) 1.50
Esophageal perforation in South of Sweden: results of surgical treatment in 125 consecutive patients. BMC Surg (2010) 1.07
Boerhaave's syndrome: Thoracolaparoscopic approach. J Minim Access Surg (2010) 1.02
The sealing effect of a fibrin tissue patch on the esophageal perforation area in primary repair. World J Surg (2007) 0.99
How to treat esophageal perforations when determinants and predictors of mortality are considered. World J Surg (2009) 0.90
Esophageal perforation caused by external air-blast injury. J Cardiothorac Surg (2010) 0.87
Esophageal stents for less invasive treatment of mediastinitis. Wideochir Inne Tech Maloinwazyjne (2014) 0.86
Oesophageal perforation: a diagnostic and therapeutic challenge in a resource limited setting. A report of three cases. J Cardiothorac Surg (2011) 0.84
Treatment of esophageal perforation in a referral center in taiwan. Surg Today (2005) 0.84
Management of thoracic esophageal perforation. World J Surg (2014) 0.83
Removal of impacted esophageal foreign bodies with a dual-channel endoscope: 19 cases. Exp Ther Med (2013) 0.82
Evaluation of urgent esophagectomy in esophageal perforation. Arq Bras Cir Dig (2015) 0.81
Surgical treatment of esophageal perforations: the importance of a primary repair. Surg Today (2012) 0.75
Evaluation of recovery in iatrogenic evoked acute mediatinitis. Inflammation (2013) 0.75
The success of surgery in the first 24 hours in patients with esophageal perforation. Eurasian J Med (2014) 0.75
Esophageal perforations. Ann Thorac Surg (2004) 0.75
Indolent form of mediastinitis caused by oesophageal perforation from fish bone ingestion. BMJ Case Rep (2009) 0.75
External air compression: A rare cause of blunt esophageal injury, managed by a stent. Int J Surg Case Rep (2014) 0.75
When should large benign tumours in posterior mediastinum be resected? J Thorac Dis (2013) 0.75
Normal chest X-ray should not mislead. BMJ Case Rep (2013) 0.75
Esophagectomy for a traumatic esophageal perforation with delayed diagnosis. World J Gastrointest Surg (2009) 0.75
Non operative management of traumatic esophageal perforation leading to esophagocutaneous fistula in pediatric age group: review and case report. World J Emerg Surg (2015) 0.75
Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med (2011) 4.59
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg (2010) 4.23
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res (2009) 3.03
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst (2010) 2.79
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res (2005) 2.73
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database. Eur J Cardiothorac Surg (2012) 2.37
Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 2.22
Tumor size predicts survival within stage IA non-small cell lung cancer. Chest (2003) 2.18
Use of bicaval dual-lumen catheter for adult venovenous extracorporeal membrane oxygenation. Ann Thorac Surg (2011) 2.11
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. J Clin Oncol (2006) 2.10
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci U S A (2003) 2.09
Hepatitis C virus-infected resident: end of residency, end of career? Ann Thorac Surg (2013) 2.03
Comparative effectiveness of robotic-assisted vs thoracoscopic lobectomy. Chest (2014) 1.98
Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients. Ann Thorac Surg (2012) 1.74
Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care (2012) 1.73
Comparative analysis of diaphragmatic hernia repair outcomes using the nationwide inpatient sample database. Arch Surg (2012) 1.72
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) (2008) 1.71
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg (2008) 1.67
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol (2011) 1.66
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res (2012) 1.57
Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. J Thorac Cardiovasc Surg (2009) 1.57
Use of carotid-subclavian arterial bypass and thoracic endovascular aortic repair to minimize cerebral ischemia in total aortic arch reconstruction. J Thorac Cardiovasc Surg (2010) 1.54
Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant. J Occup Environ Hyg (2007) 1.51
Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. Eur J Cardiothorac Surg (2012) 1.51
A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation. J Am Coll Cardiol (2009) 1.51
Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg (2013) 1.51
Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med (2014) 1.49
Managing the small pulmonary nodule discovered by CT. Chest (2004) 1.49
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming. Proc Natl Acad Sci U S A (2008) 1.49
Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma. Ann Thorac Surg (2005) 1.48
Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg (2005) 1.48
Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg (2008) 1.46
Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. J Immunol Methods (2008) 1.43
Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). J Am Vet Med Assoc (2009) 1.43
Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid? Ann Thorac Surg (2007) 1.42
Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease. Ann Thorac Surg (2011) 1.41
Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008). J Am Vet Med Assoc (2014) 1.41
Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol (2002) 1.41
Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation. Respirology (2014) 1.41
Two-stage end-to-end reconstruction of long-segment tracheal defects with a bioabsorbable scaffold grafting technique in a canine model. Ann Thorac Surg (2012) 1.39
Influence of physico-chemical changes on enzymatic digestibility of ionic liquid and AFEX pretreated corn stover. Bioresour Technol (2011) 1.39
Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery. J Thorac Cardiovasc Surg (2012) 1.38
Insertion of bicaval dual lumen extracorporeal membrane oxygenation catheter with image guidance. ASAIO J (2011) 1.36
Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc (2013) 1.34
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. J Immunol (2004) 1.33
Transition of cellulose crystalline structure and surface morphology of biomass as a function of ionic liquid pretreatment and its relation to enzymatic hydrolysis. Biomacromolecules (2011) 1.31
Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis (2004) 1.30
Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2006) 1.28
Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. Cancer Res (2005) 1.26
CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med (2007) 1.25
Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study. Crit Care (2014) 1.25
Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med (2006) 1.23
Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg (2002) 1.21
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg (2002) 1.21
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immun (2007) 1.21
Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice. Lung Cancer (2013) 1.20
Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med (2005) 1.17
Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors. J Thorac Cardiovasc Surg (2010) 1.16
Subclavian artery cannulation for venoarterial extracorporeal membrane oxygenation. ASAIO J (2012) 1.16
Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg (2007) 1.15
Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin. Ann Thorac Surg (2009) 1.14
Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells(). Cell Med (2012) 1.14
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clin Cancer Res (2009) 1.14
Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg (2011) 1.12
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination. J Immunol (2009) 1.12
Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer. Int J Cancer (2009) 1.12
The efficacy of EBUS-guided transbronchial needle aspiration for molecular testing in lung adenocarcinoma. Ann Thorac Surg (2013) 1.12
CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Proc Natl Acad Sci U S A (2002) 1.11
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival. Int J Cancer (2010) 1.11
Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann Thorac Surg (2006) 1.10
Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. Ann Thorac Surg (2004) 1.10
Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit (2004) 1.08
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg (2008) 1.07
Surgical management of thoracic malignancies invading the heart or great vessels. Ann Thorac Surg (2004) 1.07
Impact of the surgical technique on pulmonary morbidity after esophagectomy. Ann Thorac Surg (2011) 1.06
Surgical resection for lung cancer in the octogenarian. Chest (2004) 1.05
Lobectomy in octogenarians with non-small cell lung cancer: ramifications of increasing life expectancy and the benefits of minimally invasive surgery. Ann Thorac Surg (2011) 1.04
Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules. Ann Surg (2016) 1.03
The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med (2015) 1.02
Technical aspects and outcomes of tracheobronchoplasty for severe tracheobronchomalacia. Ann Thorac Surg (2011) 1.01
Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer (2003) 1.00
Safe transport of critically ill adult patients on extracorporeal membrane oxygenation support to a regional extracorporeal membrane oxygenation center. ASAIO J (2011) 1.00
Definitive therapy for isolated esophageal metastases prolongs survival. Ann Thorac Surg (2012) 0.99
CT screening for lung cancer: past and ongoing studies. Semin Thorac Cardiovasc Surg (2005) 0.99
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Ann Thorac Surg (2009) 0.99
Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg (2013) 0.98
Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism. Cancer Res (2005) 0.98
Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor. Mol Cancer Res (2013) 0.97